Pulmonary Hypertension

Defined as a mean pulmonary artery pressure (mPAP) >20 mmHg on right heart catheterization Common TTE findings include:

  • Elevated right ventricular systolic pressure (RVSP)
  • Right heart dilation or dysfunction
  • TR jet velocity >2.8 m/s
  • Signs of right heart strain
GroupEtiologyExamplesWorkupTreatment
1PAH Idiopathic, CTD, HIV, drugsANA, HIV, LFTs, RHC (pre-capillary), V/Q scanERA, PDE5i, prostacyclins, diuretics, O₂, CCB (if vasoreactive)
2Left Heart DiseaseHFrEF, HFpEF, valvular diseaseTTE, BNP, RHC (post-capillary, wedge >15)Optimize HF (ACEi/ARB, BB, diuretics), valve repair/replacement
3Lung Disease/HypoxiaCOPD, ILD, OSA, altitudePFTs, Oximetry, ABG, HRCTOxygen if hypoxic, treat lung disease; PAH meds usually not indicated
4CTEPHPrior PE, thrombophiliaV/Q scan (sensitive), CT PA, RHCAnticoagulation, PTE surgery, riociguat or BPA if inoperable
5MultifactorialSarcoid, sickle cell, CKDTailored labs, imaging, biopsiesTreat underlying disease; PAH therapies case-by-case

  • Estimated RAP: 3-15mmHg based on IVC diameter and collapsibility: If <2.1cm and >50% collapse = 3mmHg, If >2.1cm or <50% collapse = 8mmHg, if >2.1cm and <50% collapse = 15mmHg
  • TR peak velocity: ≥2.8 m/s → Suggests elevated pulmonary pressures
  • Estimated RVSP: RVSP ≈ 4 × (TR peak velocity)² + RAP
  • PH severity: Mild (35–44 mmHg), moderate (45–59 mmHg), or severe (≥60 mmHg)

RVSP Calculator


If RVSP elevated or etiology unclear, confirm PH with right heart cath

SeveritymPAP (mmHg)
Normal< 20
Borderline20–24
Mild PH25–34
Moderate PH35–44
Severe PH≥ 45
  • PCWP (wedge pressure)
    • ≤15 mmHg = pre-capillary (Groups 1, 3, 4)
    • 15 mmHg = post-capillary (Group 2)
  • PVR
    • ≥3 Wood units + high PAWP = combined pre- and post-capillary (Group 2/5 overlap)

Right Heart Cath PH Calculator











  • Labs: CBC, BMP, LFTs, TSH, HIV, ANA, BNP, troponin
  • V/Q scan: rule out CTEPH (Group 4)
  • PFTs, Oximetry, HRCT: if ILD or OSA suspected
  • Diuresis: ***
  • Oxygen goal: >92%

Etiologies: idiopathic, connective tissue disease, HIV, drugs
Treatment:

  • PDE-5 inhibitors: sildenafil 20 mg TID, tadalafil 40 mg daily
  • Endothelin receptor antagonists: ambrisentan, macitentan
  • sGC stimulator: riociguat 1–2.5 mg TID (avoid with PDE5i)
  • Prostacyclins: epoprostenol (IV), treprostinil
  • Consider vasoreactivity testing → CCBs if positive
  • Refer to PH specialty center for advanced therapies